The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Reddick Andrew D since 2009.
The trader's CIK number is 1260882.
At the time of the last reporting, Reddick Andrew D was the President and CEO of Acura Pharmaceuticals, Inc. (stock ticker symbol ACUR).
Also see all insider trading activities at Acura Pharmaceuticals, Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2011 | ACUR | 0 | $0 | 0 | $0 | 112,500 | $146,250 |
| 2009 | ACUR | 0 | $0 | 0 | $0 | 425,000 | $552,500 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2011-04-04 | ACUR | Option Ex | 112,500 | 1.30 | 146,250 |
| 2009-11-24 | ACUR | Option Ex | 425,000 | 1.30 | 552,500 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Reddick Andrew D (President and CEO of Acura Pharmaceuticals, Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.